The malin-laforin complex suppresses the cellular toxicity of misfolded proteins by promoting their degradation through the ubiquitin-proteasome system by Garyali, Punitee et al.
The malin–laforin complex suppresses the cellular
toxicity of misfolded proteins by promoting
their degradation through the
ubiquitin–proteasome system
Punitee Garyali{, Pratibha Siwach{, Pankaj Kumar Singh, Rajat Puri, Shuchi Mittal,
Sonali Sengupta, Rashmi Parihar and Subramaniam Ganesh
Department of Biological Sciences and Bioengineering, Indian Institute of Technology, Kanpur 208016, India
Received August 16, 2008; Revised and Accepted November 19, 2008
Lafora disease (LD), a progressive form of inherited epilepsy, is associated with widespread neurodegenera-
tion and the formation of polyglucosan bodies in the neurons. Laforin, a protein phosphatase, and malin, an
E3 ubiquitin ligase, are two of the proteins that are defective in LD. We have shown recently that laforin and
malin (referred together as LD proteins) are recruited to aggresome upon proteasomal blockade, possibly to
clear misfolded proteins through the ubiquitin–proteasome system (UPS). Here we test this possibility using
a variety of cytotoxic misfolded proteins, including the expanded polyglutamine protein, as potential
substrates. Laforin and malin, together with Hsp70 as a functional complex, suppress the cellular toxicity
of misfolded proteins, and all the three members of this complex are required for this function. Laforin
and malin interact with misfolded proteins and promote their degradation through the UPS. LD proteins
are recruited to the polyglutamine aggregates and reduce the frequency of aggregate-positive cells. Taken
together, our results suggest that the malin–laforin complex is a novel player in the neuronal response to
misfolded proteins and could be potential therapeutic targets for neurodegenerative disorders associated
with cytotoxic proteins.
INTRODUCTION
Protein quality control is a stringent and critical feature of
intracellular homeostasis. Irreversibly unfolded or misfolded
proteins resulting from defects in the encoded proteins and/
or proteasomal stress are rapidly degraded via the ubiquitin–
proteasome system (UPS) (1,2). A striking pathological hall-
mark of many neurodegenerative disorders is the presence of
ubiquitin-positive, intracellular inclusion bodies in affected
regions of the brain (3). These inclusions, in the majority of
such cases, are thought to be the aggregates of non-native neuro-
toxic proteins (hereafter referred to as ‘misfolded proteins’)
that accumulate over time (2,3). Examples of toxic proteins
include, but not limited to, polyglutamine proteins, poly-
alanine proteins and the mutant forms of a-synuclein and
superoxide dismutase (2,3). Aggregates of these misfolded
proteins are also known to recruit molecular chaperones and
components of the UPS, thereby raising the possibility that
an overload on the UPS is likely to promote the neurodegen-
erative process (2–4). This notion was strengthened by the
findings that overexpression of chaperones and/or E3
ubiquitin–protein ligases ameliorated the cellular toxicity
of misfolded proteins in cellular and animal models (5–9).
Conversely, the inhibition of proteasome or defect in the
UPS was shown to promote cellular toxicity by increasing
the load of misfolded proteins in the cellular milieu (9,10).
Thus, an imbalance between the capacity of UPS to clear
toxic protein and the synthesis of aggregation-prone, mis-
folded proteins might initiate the onset and the progression
of diseases symptoms (2,11).
UPS relies on the transfer of ubiquitin molecules to the
target protein through three enzymatic steps, with the key
steps of substrate selection and ubiquitin transfer being
delegated to an enzyme called ubiquitin–protein ligase or
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the E3 enzyme (1). The complex process of UPS-mediated
protein degradation is influenced by a large number of regulat-
ory proteins, and E3 ligases offer substrate specificity to this
process (1). Not surprisingly, therefore, mutations in genes
involved in, or affecting, the UPS have been linked to
several neurodegenerative diseases associated with protein
misfolding (2). For example, Parkinson’s disease (PD) is
caused by mutations in parkin, an E3 ubiquitin ligase, and
UCH-L1, a deubiquitinating enzyme (12–14). Similarly,
mutations in the NHLRC1 gene that encodes malin E3 ubiqui-
tin ligase result in Lafora disease (LD), a neurodegenerative
progressive epilepsy (15,16). Both malin and parkin are
RING finger ubiquitin ligases, and the inhibition of proteaso-
mal activity causes both proteins to form centrosomal aggre-
some that co-localizes with the UPS components (17,18).
Aggresomes are thought to provide a subcellular locale for
the E3 enzymes to ubiquitinate and degrade misfolded proteins
when the cellular levels of the latter increase beyond a
threshold (4,19). Corroborating this suggestion, the over-
expression of parkin was shown to reduce the aggregation
and cytotoxicity of ataxin-1-containing expanded polygluta-
mine repeats (8) and mutant a-synuclein (20). Intriguingly,
expanded polyglutamine proteins and mutant a-synuclein are
known to get recruited to the aggresome upon overexpression
or when the proteasome is blocked (21–23). Thus, misfolded
proteins that target aggresomes are potential substrates for
the aggresome-positive E3 ligases.
In addition to the NHLRC1 gene, LD may also be caused by
defects in the gene EPM2A that codes for a dual-specificity
protein phosphatase, named laforin (24,25). Laforin is also
known to interact with malin and serves as one of its substrates
(16,18). We have shown recently that both malin and laforin
proteins, hereafter referred to as LD proteins, are recruited
to aggresome in response to proteasomal impairment,
suggesting that the LD proteins might work together in the
UPS pathway (18). Because malin and laforin are recruited
to the aggresome, we addressed the possibility of whether
the LD proteins would promote the degradation of misfolded
proteins and rescue cells from their cytotoxic effect. We
show here that laforin and malin form a functional complex
that facilitates the clearance of misfolded proteins from the
cellular milieu.
RESULTS
Overexpression of LD proteins decreases the cellular
toxicity of misfolded proteins in neuronal
and non-neuronal cells
Expanded polyglutamine proteins, polyalanine proteins and
a-synuclein mutants are known to form aggresome-like struc-
tures either on their own or when expressed in the presence
of MG132, a proteasomal inhibitor (21–23). We therefore
evaluated the truncated huntingtin protein with 97 glutamine
repeats and tagged to green fluorescent protein (tHtt-Q97-
GFP) [associated with polyglutamine disorders (reviewed
in 2)], 20 alanine repeats tagged to the carboxyl terminal of
GFP (GFP-A20) [polyalanine disorders (reviewed in 2)], 20
aspartic acid repeats tagged to the carboxyl terminal GFP
(GFP-D20) [skeletal dysplasias (26)] or the GFP-tagged
a-synuclein missense mutant A30P protein [PD (27)] as
potential substrates for malin and laforin. As demonstrated
earlier (21–23), the overexpression of each one of these pro-
teins, hereafter referred to as misfolded proteins, resulted in
the formation of perinuclear aggregates when the proteasome
is blocked or otherwise (Supplementary Material, Figs S1 and
S2). A construct that expresses GFP-fused to 20 repeats of
glutamine residues (GFP-Q20) or the wild-type a-synuclein
was used as the control (Supplementary Material, Fig. S1).
One hundred percent of the cells that expressed tHtt-Q97-GFP,
GFP-A20, GFP-D20, GFP-tagged a-synuclein mutant A30P
protein or its wild-type form exhibited perinuclear aggregates
upon MG132 treatment (Supplementary Material, Figs S1
and S2).
The transient expression of tHtt-Q97-GFP, GFP-A20,
GFP-D20 or the a-synuclein A30P mutant protein has induced
substantial cell death in COS-7 cells (Fig. 1A and B and Sup-
plementary Material, Fig. S1). Intriguingly, the co-expression
of wild-type malin or laforin significantly reduced the cell
death caused by these misfolded proteins (P , 0.005)
(Fig. 1A and B). For example, the toxicity of tHtt-Q97-GFP
was brought down to 50% by malin or laforin when
co-expressed. This protective effect, however, was not seen
when the LD-associated mutant forms of malin or laforin or
when b-galactosidase was co-expressed (Fig. 1A–C). We next
explored whether the observed protective effect of LD proteins
can also be replicated in neuronal cells. As shown in Figure 2A,
the co-expression of LD proteins has significantly reduced the
toxicity of each of the four misfolded proteins tested in the
Neuro2A mouse neuroblastoma cell line, suggesting that
laforin and/or malin proteins confer protection against toxic
misfolded proteins regardless of the cell line used.
Partial knockdown of LD proteins enhances the toxicity
of misfolded proteins in neuronal cells
We have also checked the effect of knockdown of endogenous
laforin or malin on the toxicity conferred by the misfolded
proteins in Neuro2A cells. The RNAi-mediated knockdown
of EPM2A or the NHLRC1 gene was validated (see Sup-
plementary Material, Fig. S4), and Nuero2A cells were
co-transfected with tHtt-Q97-GFP with an shRNAi construct
for the knockdown of laforin, malin or an empty vector.
A significant decrease in the survival rate was observed
when tHtt-Q97-GFP was co-expressed with the shRNA con-
struct for the knockdown of laforin or the malin protein
when compared with the one that co-expressed the empty
vector (Fig. 2B). However, loss of laforin or malin does not
affect the survival of cells when they do not express
tHtt-Q97-GFP (Fig. 2B). Similar results were obtained with
the COS-7 cell line (data not shown).
Malin and laforin proteins suppress the toxicity of
misfolded proteins by promoting their degradation
In order to check whether malin and laforin rescue cells from
the toxicity of misfolded protein by enhancing their rate of
degradation, we co-expressed tHtt-Q97-GFP with either the
wild-type malin, laforin or their catalytic mutants and looked
for the fold difference in the cellular levels of tHtt-Q97-GFP
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by immunoblot analysis by loading equal amount of total
protein. A significant reduction in the cellular levels of
tHtt-Q97-GFP was seen when the misfolded protein was
expressed with the wild-type malin or laforin when compared
with those that co-expressed the mutant forms or that were
treated with a proteasomal inhibitor (Supplementary Material,
Fig. S3B). Thus, malin and laforin likely facilitate the
degradation of misfolded proteins through the proteasomal
system. To further prove this point, we expressed tHtt-Q97-GFP
with increasing concentrations of wild-type or the mutant forms
of malin or laforin and checked for its cellular levels by the
immunoblot analysis (Fig. 3). We show that the tHtt-Q97-GFP
protein levels were decreased in a malin or laforin dose-
dependent manner, and such an effect was not observed for
the mutant form (compare the signal intensities of tHtt-Q97-
GFP in Fig. 3A with B and C and Fig. 3D with E and F).
We next wanted to check whether LD proteins reduce the
cellular levels of misfolded proteins by enhancing their rate
of degradation. For this, we have used an inducible system,
wherein the expression of tHtt-Q97-GFP could be modulated
by ponasterone (28) (Fig. 4A). The inducible tHtt-Q97-GFP
was expressed for 12 h in Neuro2A cells either alone or with
the wild-type or the mutant forms of laforin/malin, and then
processed for the pulse-chase analysis by withdrawing the
ponasterone from the medium for various time points
(Fig. 4B). As shown in Figure 4B and C, the overexpression
of wild-type malin or laforin, but not their mutants, had sig-
nificantly decreased the half-life of tHtt-Q97-GFP.
LD proteins need each other to suppress the cellular
toxicity of misfolded proteins
We next examined whether malin would require laforin, and
vice versa, to confer the protection against the toxicity of
misfolded proteins. For this, we transiently co-expressed
tHtt-Q97-GFP with malin and knocked down laforin or
co-expressed tHtt-Q97-GFP with laforin, but knocked down
malin in both COS-7 and Neuro2A cell lines (Fig. 5A and
B). Control experiments were performed in parallel, wherein
tHtt-Q97-GFP was co-expressed with empty knockdown
vector and laforin or malin. As shown in Figure 5A and B,
the overexpression of malin was not able to suppress the
toxicity of tHtt-Q97-GFP when laforin was knocked down,
and similar observations were made for laforin when malin
was knocked down in both the cell lines tested. Thus, laforin
and malin appear to function together as a complex, and the
loss of anyone of them would make the other protein ineffec-
tive against misfolded proteins.
We next checked whether the LD proteins require each
other for reducing the cellular levels of misfolded protein.
For this, we co-expressed tHtt-Q97-GFP with the knockdown
construct for laforin and increasing concentrations of wild-
type malin (Fig. 5C). Conversely, the tHtt-Q97-GFP was
expressed with the knockdown construct for malin and
increasing concentrations of laforin protein (Fig. 5D). Malin
was unable to reduce the cellular levels of tHtt-Q97-GFP
when the expression of laforin was blocked (Fig. 5C).
Similar observations were made for laforin when malin was
knocked down (Fig. 5D). However, co-expression of empty
shRNA vector did not affect the protective effect of laforin
or malin on tHtt-Q97-GFP (Fig. 5E and F).
Malin and laforin physically interact with misfolded
proteins
We have also examined whether malin and laforin promote the
degradation of misfolded proteins by physically interacting
with them. For this, we used tHtt-Q97-GFP and GFP-D20 as
two distinct misfolded proteins and tested for their interaction
with laforin or malin. As a control, we used an overexpression
Figure 1. Bar diagrams showing levels of toxicity (percent cells showing
apoptotic features) in COS-7 cells transiently transfected with expression con-
structs as indicated. The value of each bar represents the mean average of three
independent transfections, with a minimum of 250 transfected cells scored for
each transfection. Error bars indicate the SD of the mean. (A) Difference in the
number of cells showing apoptotic features (cells in which the nucleus is
fragmented into dense granular particles—see Supplementary Material,
Fig. S1B and D) between the groups of cells that express only the misfolded
protein when compared with groups that co-express the wild-type (WT) or the
mutant forms of malin (C26S and NHL-del) (18) was calculated. (B) Differ-
ence in the number of cells showing apoptotic features between the groups
of cells that express only the misfolded protein when compared with groups
that co-express the wild-type (WT) or the mutant forms of laforin (W32G
and Q293L) (18) was calculated. (C) Cytotoxicity of cells that co-express
misfolded proteins (as indicated) and b-galactosidase was calculated.
(D) Cytotoxicity of cells that express the GFP, GFP-Q20 or the wild-type
a-synuclein (a-Syn-WT) is shown. The difference in the P-value less than
0.05 or 0.005 was denoted over the bar by a single asterisk or double asterisks
(), respectively, as derived from a paired t-test.
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construct for GFP. As shown in Figure 6A, the His-tagged
malin and laforin were able to pull-down the tHtt-Q97-GFP
protein. Laforin and malin were also able to pull-down
GFP-D20, and but no interaction was found with GFP,
suggesting that the observed interaction with LD proteins is
not limited to expanded polyglutamine protein but a generic
response to a wide variety of misfolded proteins. As laforin
and malin require each other to degrade the misfolded pro-
teins, we next checked whether the observed interaction
between misfolded protein and malin is independent of
laforin (or vice versa) or not. For this, we have chosen
GFP-D20 because of its robust expression and co-expressed
it with laforin and knocked down malin using the shRNA con-
struct. In parallel, GFP-D20 was expressed with malin, and
laforin was knocked down (Fig. 6B). As a control, laforin or
malin was co-expressed with GFP-D20 with the shRNA
empty vector. As shown in Figure 6B, laforin was able to
pull-down GFP-D20 in the presence and absence of malin.
However, malin was unable to pull GFP-D20 when laforin
was knocked down. Taken together, these observations
suggest that, within the malin–laforin complex, laforin is the
one that makes direct interactions with the misfolded proteins.
Malin–laforin complex degrades misfolded proteins
through the ubiquitin–proteasomal pathway
As malin is an E3 ubiquitin ligase and malin forms a complex
with laforin, we wanted to check whether the malin–laforin
complex promotes the degradation of the misfolded
proteins through the UPS. For this, we have used a mutant
ubiquitin, K48R, which is known to block the K48-linked
polyubiquitination when overexpressed (29). We have used a
construct that expresses wild-type ubiquitin as the control
(Fig. 7A). As shown in Figure 7A, malin or laforin was
unable to rescue the toxicity of tHtt-Q97-GFP when
co-expressed with the ubiquitin mutant K48R, suggesting
that the malin–laforin complex rescues the cells from the
toxicity of misfolded proteins through polyubiquitination. In
contrast, the co-expression of wild-type ubiquitin, as expected,
did not alter the protective effect of laforin or malin. These
observations were further strengthened by looking at the
ubiquitinated forms of tHtt-Q97-GFP in pull-down assays.
As shown in Figure 7B, the co-expression of wild-type
malin or wild-type laforin resulted in the increased cellular
levels of ubiquitinated tHtt-Q97-GFP when compared with
cells that had co-expressed the mutant forms of malin/laforin
or the empty vector. Similarly, ubiquitinated tHtt-Q97-GFP
was not observed when the ubiquitin mutant K48R was
co-expressed (Fig. 7B). These observations demonstrate that
the LD proteins promote the degradation of misfolded
protein via the polyubiquitination process.
The ubiquitin–proteasome and autophagy–lysosome path-
ways are the two major routes for the clearance of unwanted
and misfolded toxic proteins in eukaryotic cells (3). We
have therefore tested whether malin and laforin use, in
addition to the UPS, the autophagy–lysosome pathway for
the clearance of misfolded proteins. For this, COS-7 or
Neuro2A cells were co-transfected with wild-type malin or
laforin and tHtt-Q97-GFP and tested for cellular toxicity
using a panel of inhibitors, a strategy that had been used pre-
viously for the study of polyglutamine and polyalanine pro-
teins (30) (see Fig. 8 for details on inhibitors). Blocking
Figure 2. Bar diagrams showing levels of toxicity (percent cells showing apoptotic features) in Neuro2A cells transfected with expression constructs as indicated.
(A) Difference in the number of cells showing apoptotic features between the groups of cells that express only the misfolded protein (pcDNA) when compared
with the groups that co-express malin or laforin was calculated. (B) The effect of loss of endogenous malin or laforin on the cytotoxicity of the tHtt-Q97-GFP
protein in Neuro2A cells was evaluated. For this, the number cells that were transfected with tHtt-Q97-GFP and an empty vector for the RNAi knockdown
(shRNA vector) that did not show apoptotic features after 36 h of transfection were considered as 100%. This value was compared with the experimental
groups, in which tHtt-Q97-GFP was co-expressed with the knockdown construct for malin or laforin and difference in the survival rate was calculated.
Control experiments, wherein the laforin/malin knockdown construct or the vector backbone was co-expressed with GFP, were carried out to check whether
loss of laforin or malin itself is toxic to the cell. The value of each bar represents the mean average of three independent transfections, with a minimum of
250 transfected cells scored for each transfection. Error bars indicate the SD of the mean. The difference in the P-value ,0.05 or 0.005 was denoted over
the bar by a single asterisk or double asterisks (), respectively, as derived from a paired t-test. The efficiency of the knockdown construct was established
by immunoblotting (see Supplementary Material, Fig. S4).
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autophagy, autophagosome–lysosome fusion or the lysosome
function had significantly increased the number of GFP-
positive cells exhibiting apoptotic features (Fig. 8). However,
the effect of proteasome blockade on cell survival was far
more significant, and the proportion of apoptotic cells exceeded
the group that expressed only tHtt-Q97-GFP (Fig. 8). Thus, the
proteasomal system appears to be the primary route for the
clearance of misfolded proteins by the malin–laforin complex.
Malin and laforin interact with Hsp70 and all the three
members of this complex are required for the suppression
of cellular toxicity of misfolded proteins
As malin, with the help of laforin, appears to recognize a
diverse set of proteins for the polyubiquitination process, we
speculated that malin might interact with Hsp70 to target the
misfolded proteins for proteasomal degradation. To test our
hypothesis, we first examined, by cell death assay, whether
knockdown of endogenous Hsp70 abrogates the protection
against cell death conferred by malin or laforin. As shown
in Figure 9A and B, malin or laforin was unable to rescue
cell death promoted by tHtt-Q97-GFP when Hsp70 was
knocked down. This observation demonstrates that Hsp70 is
required for malin and laforin to impart the cytoprotective
effect. Conversely, the overexpression of Hsp70 rescued the
cells from the toxicity of tHtt-Q97-GFP at levels similar to
that of wild-type malin or laforin, either on its own or when
co-expressed with the wild-type malin or laforin (Fig. 9A
and B). We have therefore checked whether Hsp70 would
require malin or laforin for its cytoprotective function. For
this, we transiently co-expressed Hsp70 and tHtt-Q97-GFP
along with the knockdown shRNA construct for malin or
laforin and scored for cell death (Fig. 9C). The control set,
wherein Hsp70 and tHtt-Q97-GFP were co-expressed with
an empty vector for shRNA, showed significant reduction in
the toxicity of tHtt-Q97-GFP (Fig. 9C). In contrast, the over-
expression of Hsp70 was not able to rescue the cells from
the toxicity of tHtt-Q97-GFP when the expression laforin or
malin was knocked down (Fig. 9C), suggesting that Hsp70
requires both laforin and malin to reduce the toxicity of
misfolded proteins.
We next examined whether malin and laforin physically
interact with Hsp70. As shown in Figure 9D, malin and
laforin were able to pull-down Hsp70. As malin and laforin
function as a complex, we next checked which of these two
proteins interact with Hsp70. As shown in Figure 9E, laforin
was able to pull-down Hsp70 even in the absence of malin,
whereas malin was unable to pull Hsp70 when the expression
of laforin was blocked, suggesting a direct interaction between
Hsp70 and laforin. Finally, we have also checked whether
Hsp70 is critical for the interaction between misfolded pro-
teins and laforin/malin. As shown in Figure 9F, laforin was
able to pull-down GFP-D20 even in the absence of Hsp70,
whereas malin could not. Thus, the interaction of misfolded
proteins with laforin appears to be independent of Hsp70,
but for malin, it is Hsp70-dependent.
Malin–laforin complex associates with cellular aggregates
of tHtt-Q97-GFP and facilitates their clearance
We checked whether malin and laforin would co-localize
with tHtt-Q97-GFP aggregates and enhance their clearance.
For this, COS-7 cells were co-transfected with tHtt-Q97-GFP
and laforin or malin and processed for indirect immunofluor-
escence staining. Under normal cell culture conditions,
malin localizes to both nucleus and cytoplasm in COS-7
cells, whereas the localization of laforin was restricted to the
cytoplasm (18). When expressed with tHtt-Q97-GFP,
however, the majority of the malin or laforin proteins targeted
the tHtt-Q97-GFP aggregates and co-localized with them
(Fig. 10A). We therefore reasoned that, when expressed
together, the malin–laforin complex reduces the cellular
toxicity of misfolded proteins by ‘dissolving’ the aggregates.
We therefore transiently expressed tHtt-Q97-GFP alone or
with the wild-type malin or laforin and scored for aggregate-
positive cells with GFP expression (Fig. 10B). When
expressed alone, 25% of the GFP-positive cells show cyto-
plasmic and/or nuclear aggregates. In the presence of wild-
type malin or laforin, however, there was a significant
decrease in the number of aggregate-positive cells (8%)
(Fig. 10B). In contrast, knockdown of laforin or malin had
increased the frequency of cells having aggregates, but
this difference was not statistically significant (Fig. 10B).
Figure 3. Laforin and malin degrade the misfolded proteins in a dose-
dependent manner. Transfection was performed in Neuro2A cells in 24-well
plates with expression constructs for tHtt-Q97-GFP (400 ng/well) and increas-
ing proportion of constructs (0, 100, 200 or 400 ng/well in lanes 1–4, respect-
ively) for the wild-type (WT) (A) or the mutant form of malin (B and C) or the
wild-type laforin (D) or its mutant form (E and F), as indicated. The wild-type
and mutant forms of laforin and malin proteins were tagged with Myc-epitope.
In each transfection, the total amount of plasmid DNA used was adjusted to
1 mg/well with the vector plasmid (pcDNA). Equal amount of whole cell
lysate from each well was resolved in SDS–PAGE and immunoblotted with
anti-GFP antibody (for tHtt-Q97-GFP), anti-Myc antibody (for laforin or
malin) or anti-g-tubulin (as loading control) to show the difference in the
cellular levels of misfolded proteins.
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Consistent with these findings, the co-expression of laforin or
malin has decreased the level of high-molecular-weight bands
of the tHtt-Q97-GFP protein trapped in the stacking gel
(Fig. 10C), suggesting that malin and laforin could bring
down the toxicity by altering the aggregation property of the
misfolded proteins.
Malin and laforin proteins are recruited to huntingtin
aggregates in the brain of HD exon-1 transgenic mice
We have also explored whether malin and laforin are recruited
to the neuronal inclusions in the R6/2 mice model for
Huntington disease (31). Using double immunofluorescence
staining, we show here that in the transgenic mice brain,
malin and laforin proteins co-localize with the aggregates of
mutant huntingtin (Fig. 11). Not all the huntingtin aggregates,
however, were positive for the LD proteins. Fifty percent
of the huntingtin aggregates in the cerebral cortex region
stained positive for the anti-laforin or anti-malin antibody
and their localization was much lower in cerebellum and
hippocampus (20%).
DISCUSSION
We have shown here that co-expression of malin or laforin
clears misfolded toxic proteins through the ubiquitin–protea-
some pathway and reduces their cellular toxicity. Although
the present set of observations was made in cellular models
under overexpression conditions, carefully chosen controls,
as discussed below, suggest that the observed properties of
LD proteins are not experimental artifacts. The experiments
were performed in two different cell lines (COS-7 and
Neuro2A), and identical observations were made, suggesting
that the observed effects were not restricted to a given cell
line. With regard to the toxicity conferred by the misfolded
proteins, a significant reduction in the frequency of cell
death was seen only when the wild-type malin or laforin
was co-expressed. Neither their mutant forms nor did the
b-galactosidase protein showed any appreciable effect on the
viability of cells co-expressing the misfolded proteins. This
suggests that functional malin and laforin were required for
the rescue and that the observed difference in the toxicity
was not just due to the co-expression of any protein.
Thirdly, partial knockdown of endogenous malin or laforin
led to an increase in the toxicity of misfolded proteins.
Finally, we show that laforin and malin co-localize with the
mutant huntingtin aggregates in cellular and animal models.
Malin is known to ubiquitinate and promote the clearance of
its substrates through proteasomal degradation (16,18,32–34).
Consistent with this notion, we show here that the wild-type
malin and wild-type laforin reduce the cellular levels of mis-
folded proteins in a dose-dependent manner, and this effect
was abrogated when the cells were treated with a proteasomal
inhibitor. A reduction in the cellular toxicity of misfolded
proteins should therefore be due to their reduced cellular
levels, as proteasomal inhibition leads to an increase in cell
Figure 4. Laforin and malin decrease the cellular toxicity of misfolded proteins by reducing their half life. (A) Neuro2A cells were transiently co-transfected with
an inducible expression construct for tHtt-Q97-GFP and the receptor for ecdysone (pVgRXR) and either treated (þ) or not treated (2) with ponesterone. Twenty
four hours after the induction, the cells were harvested and immunoblotted with anti-GFP antibody to detect the expression of tHtt-Q97-GFP. The same blot was
probed with anti-g-tubulin as the loading control. (B) Neuro2A cells were transiently transfected with the inducible construct for tHtt-Q97-GFP, ecdysone recep-
tor (pVgRXR) and with empty vector (pcDNA), wild-type (WT) malin, laforin or their mutant forms as indicated. Twenty four hours post-transfection, the cells
were treated with ponasterone A for 12 h. The cells were washed and supplemented with fresh medium without ponesterone A and chased for different time
periods, as indicated in the figure. Cells were then collected and processed for immunoblotting using anti-GFP antibody (for tHtt-Q97-GFP) and anti-g-tubulin
antibody (loading control). (C) The line graph indicates the relative intensity of band for tHtt-Q97-GFP when compared with g-tubulin at each time point for the
pulse-case shown in (B). For the calculation, the signal intensity for anti-GFP and anti-g-tubulin antibodies of the lane representing ‘0 h’ was considered together
as 100%. The values represent the mean of two independent transfections (+SD), and the signal intensity in the digital images was measured using the Quantity
One Discovery Series software of Bio-Rad Laboratories.
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death frequency even in the presence of wild-type malin. This
suggestion was strengthened by our observation that the
co-expression of ubiquitin mutant K48R, suggesting that LD
proteins clear misfolded proteins primarily through the UPS
and via ubiquitination process, as shown in the ubiquitination
assays. In addition to the UPS, misfolded proteins are known
to be cleared through the autophagy–lysosome pathway (3).
Indeed, there are reports that suggest that a given substrate
could be either cleared through the UPS or the autophagy–
lysosome system (3). The present study, involving specific
blocker for the lysosome and autophagosome, suggests that
malin and laforin use the UPS as the primary route for the
clearance of misfolded proteins.
We found that malin and laforin proteins specifically bind
to the misfolded proteins and promotes their ubiquitination.
Moreover, the effect of malin and laforin on the rate of
degradation of misfolded protein was dose-dependent; higher
the level of malin or laforin, lesser the level of misfolded
proteins. These findings suggest that the observed toxicity
Figure 5. Laforin and malin function as a complex to rescue the toxicity of the
misfolded proteins. Bar diagrams show the levels of toxicity, calculated by
percentage of cells showing apoptotic features, in COS-7 (A) and Neuro2A
cells (B) transfected with combinations of expression constructs (laforin or
malin) and knockdown constructs (shRNA laforin or shRNA malin) or the
empty vector (shRNA vector), as indicated. The value of each bar represents
the mean of three independent transfections, with a minimum of 300 cells
scored for each set. Error bars represent the SD of the mean. The P-value
,0.005, calculated by a paired t-test, is denoted over the bar by double aster-
isks (). Laforin and malin function as a complex in reducing the levels of
misfolded protein (C–F). Transfection was performed in Neuro2A cells in
24-well plates with expression constructs for tHtt-Q97-GFP (300 ng/well),
knockdown construct for malin (C) or laforin (D) (shRNA-laforin/malin)
(200 ng/well) and increasing proportion of constructs (0, 100, 200 or
400 ng/well in lanes 1–4, respectively) for malin (C) or laforin (D) in
24-well plates. (E and F) Control experiments wherein the knockdown
constructs were substituted with an empty vector (shRNA-vector). In each
transfection, the total amount of plasmid DNA used was adjusted to 1 mg/
well with the vector plasmid (pcDNA). The laforin and malin proteins were
tagged with Myc-epitope. Equal amount of whole cell lysate from each well
was resolved in SDS–PAGE and immunoblotted with anti-GFP antibody
(for tHtt-Q97-GFP), anti-Myc antibody (for laforin or malin) or anti-g-tubulin
(as loading control) to show the difference in the cellular levels of misfolded
proteins.
Figure 6. Malin and laforin physically interact with misfolded proteins.
(A) Myc/His-tagged malin or laforin was co-expressed with GFP-D20,
tHtt-Q97-GFP or GFP in COS-7 cells and processed for the pull-down assay
using the Ni-affinity resin, as indicated. As a negative control, COS-7 cells
expressing tHtt-Q97-GFP but not malin or laforin were processed in parallel.
The pulled-down products (PD) and whole cell lysates (WCL) were immuno-
blotted (IB) and probed with anti-GFP or anti-Myc antibodies. Malin and
laforin were able to pull-down GFP-D20 and tHtt-Q97-GFP, but not the
GFP. The Ni-resin was unable to pull-down tHtt-Q97-GFP, demonstrating
specificity of the pull-down assay. (B) Laforin is required for the interaction
of malin with the misfolded proteins: Myc/His-tagged laforin or malin was
co-expressed with GFP-D20 and shRNA construct for malin, laforin or the
empty vector in COS-7 cells and processed for pull-down assay using the
Ni-affinity resin, as indicated. The PD and the WCL were immunoblotted
and probed with anti-GFP or anti-Myc antibody, as indicated.
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for the misfolded protein was not because of the saturation of
the proteasomal function, but could perhaps be that the cellular
machinery was unable to target the misfolded proteins to
the proteasome by failing to ubiquitinate them. Although the
role of malin is established as an E3 ubiquitin ligase, the
specific function of laforin in UPS is not clear. It is likely
that laforin acts as a ‘substrate adaptor protein’ to present
the misfolded proteins to malin, because malin was unable
to interact with the misfolded proteins when laforin was not
present. Our observations that mutant laforin was unable to
perform this function suggest that laforin might dephosphory-
late some critical factors in the chaperone–misfolded protein
complex, and this step is critical for the clearance process.
The requirement of laforin for malin to degrade misfolded
proteins resembles the findings on PTG protein, wherein the
PTG was found to interact with laforin, and the presence of
laforin was essential for the malin-mediated degradation of
PTG (33,34). Thus, laforin appears to be a critical partner
for malin’s cellular functions.
The protein quality control system is essential for the
removal of abnormal and long-lived proteins from the cellular
milieu. This system involves two groups of proteins: one that
includes molecular chaperones, such as heat shock proteins,
that recognize and aid in converting misfolded proteins to
functional forms (35). The other group represents factors
involved in the UPS pathway that degrades severely
damaged or misfolded proteins to release the amino acid resi-
dues (3). In recent years, there are growing numbers of reports
that document a functional link between chaperone systems
and proteolysis machinery, suggesting that the two systems
work together to maintain permissive cellular concentrations
of certain short-lived and abnormal proteins (36). Because
substrate recognition in the UPS is known to be regulated by
the E3 ubiquitin ligases and as the malin–laforin complex
appears to identify a diverse set of misfolded proteins, we
thought that the malin–laforin complex might use Hsp70 as
an essential component in this functional unit. We show
here that Hsp70 indeed interacts with the malin–laforin
complex and its presence is critically essential for the
complex to clear misfolded proteins. The specific affinity of
Hsp70 to misfolded proteins has been well documented
(37,38). Thus, Hsp70 might confer the apparent broader
range of substrate specificity that the malin–laforin complex
had displayed in the present study. Consistent with this
view, malin was unable to interact with misfolded proteins
when Hsp70 was knockdown. However, laforin was able to
pull the misfolded proteins even in the absence of Hsp70,
suggesting that laforin-misfolded protein interaction was inde-
pendent of Hsp70. This interaction could possibly be mediated
by chaperones other than Hsp70. In fact, chaperones such as
Hsp27 and HDJ-2 are known to interact with and ameliorate
the toxicity of misfolded proteins (7,10) and therefore it
would be of interest to check the interactions between these
chaperones and LD proteins. Intriguingly, we found that the
overexpression of Hsp70 was unable to reduce the toxicity
of misfolded proteins when laforin or malin was knocked
down. Thus, Hsp70 appears to function as a complex that
also includes malin and laforin and that the LD proteins are
essential for the complex to act on misfolded proteins. To
further support this model, we show here that the malin–
laforin complex interacts with Hsp70 even in the absence of
misfolded proteins, suggesting that the laforin and malin
Figure 7. Malin and laforin promote the degradation of misfolded toxic protein via polyubiquitination. (A) Bar diagram showing the levels of toxicity, calculated
by percentage of cells showing apoptotic features, in COS-7 cells transfected with the combination of expression constructs for tHtt-Q97-GFP, laforin, malin,
wild-type/mutant ubiquitin (K48R) and the empty vector (pcDNA), as indicated. The value of each bar represents the mean of three independent transfections,
with a minimum of 300 cells scored for each set. Error bars represent the SD of the mean. The P-value ,0.005, calculated by a paired t-test, is denoted over the
bar by double asterisks (). (B) COS-7 cells were transiently transfected with the constructs for ecdysone receptor (pVgRXR), tHtt-Q97-GFP (coding His-tagged
expanded huntingtin protein), and wild-type malin or laforin or their mutant forms as indicated and processed for the pull-down assay using the Ni-affinity resin.
The pulled-down samples (PD) and whole cell lysates (WCL) were then probed with anti-ubiquitin and anti-GFP antibodies. Arrow indicates the position of
90 kDa tHtt-Q97-GFP band in the pull-down product, and their polyubiquitinated species are identified on the left with a brace bracket.
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seem to exist in a complex with Hp70 even when the cells are
not loaded with misfolded proteins. The E3 ligases CHIP and
parkin are also known to exist and function as a complex with
Hsp70 (39). Therefore, further studies on the formation and
cellular functions of the LD protein complex are necessary
to identify and decipher the role of each component in the
control of misfolded protein response. Intriguingly, at least
four distinct E3 ubiquitin ligases (parkin, CHIP, dorfin and
E6-AP) are known to reduce the toxicity of misfolded toxic
proteins by promoting their degradation through the UPS
(5,8,40,41). However, the role of a protein phosphatase in
this process is yet to be discovered.
We have shown here that the overexpression of LD proteins
alters the aggregation property of expanded huntingtin. The
malin–laforin complex perhaps rescues the cells from the
toxicity of misfolded proteins by preventing and/or reducing
the formation of aggregates that are conformationally toxic
to the cell. It has indeed been shown recently that huntingtin
protein with expanded glutamine repeats forms conformation-
ally distinct intermediates that eventually lead to the insoluble
toxic forms (42). The recruitment of laforin and malin to
huntingtin aggregates in the cellular model and in the trans-
genic mice could possibly represent the unsuccessful or an
ongoing attempt by the LD protein complex in ‘clearing’ the
aggregates through the UPS. Thus, an imbalance between
the levels of the malin–laforin complex and the misfolded
proteins might regulate the aggregation property and the
toxicity. Studies in mice models have indeed shown that
either arresting the expression of mutant huntingtin protein
or overexpression of Hsp70 results in the reduction of
nuclear aggregates and the disease severity (6,43). Thus, the
overexpression of the malin–laforin complex could enhance
the functions of the cellular quality control system and
rescue the cells from the toxicity of misfolded proteins.
The carbohydrate-rich Lafora polyglucosan bodies are hall-
mark of LD (44,45). However, no proteinaceous inclusions are
known in LD; therefore, the relevance of the present findings
to the LD pathology is unclear as of now. It should be noted
however that Lafora bodies were stained positive for ubiquitin
and advanced glycation end-products (AGEP), suggesting the
presence of abnormal proteins in the polyglucosan aggregates
(46). AGEPs are insoluble and non-degradable products that
develop from the interaction between reducing sugars and
long-lived proteins and are known to generate oxidative
stress on proteins (46). As abnormal/damaged proteins are
known to be removed by the proteasomal system (47,48),
we have recently suggested that malin defects in LD may
lead to increased abnormal protein load in the neurons (18).
The present report strengthens our suggestion and calls for
further studies on the possible role of misfolded proteins in
the etiology of LD. In conclusion, this study highlights the
importance of the malin–laforin complex in promoting the
clearance of misfolded proteins via proteasomal degradation.
This study thus opens up a new and attractive therapeutic
pathway for polyglutamine and other neurodegenerative
disorders associated with toxic misfolded proteins.
MATERIALS AND METHODS
Reagents and antibodies
Chemicals MG132, tunicamycin, bafilomycin and 3MA
were purchased from Sigma-Aldrich India Pvt Ltd. The fol-
lowing antibodies were used in the present study: anti-GFP
(Roche, India), anti-Myc (Cell Signaling Technology, USA),
anti-g-tubulin (Sigma-Aldrich India Pvt Ltd), anti-Hsp70
(Sigma-Aldrich India Pvt Ltd), anti-FLAG (Sigma-Aldrich
India Pvt Ltd), anti-ubiquitin (Dako, Denmark), anti-laforin
(Abnowa, Taiwan, Republic of China) and anti-malin (Anti-
bodies Incorporated, USA). Anti-huntingtin antibody (S830)
was generously provided by Gill Bates. Secondary antibodies
were obtained from Jackson Immuno Research Inc. (USA).
Expression constructs
The expression vectors containing Myc- or GFP-tagged wild-
type or mutant forms of malin and laforin were described
previously (18). For generating construct to express A20, and
D20 repeats as fusion product to the GFP, two complementary
oligonucleotides having mixed codons for the amino repeats
were synthesized along with the desired restriction sites on
either end, annealed and cloned in-frame into the pEGFPC2
vector. These clones will express the repeat sequence at the car-
boxyl terminal of the GFP. The sequence of the recombinant
clones was confirmed by sequencing, and the clones were
further verified for expressing the expected size peptides in
cell lines (Supplementary Material, Fig. S3A). The GFP-tagged
truncated huntingtin Q97 expression vectors (inducible and
non-inducible) were generously provided by Lawrence Marsh
(University of California, Irvine, CA, USA). The GFP-tagged
wild-type and mutant forms of a-synuclein expression construct
Figure 8. The malin–laforin complex promotes the degradation of misfolded
proteins primarily through the proteasomal pathway. COS-7 cells were transi-
ently transfected with tHtt-Q97-GFP independently or with an expression
vector for wild-type malin (malin-WT) (A) or wild-type laforin (laforin-WT)
(B) and treated with 3-methyl adenine (3MA; a specific inhibitor of
autophagy) (30), bafilomycin A1 (an ATPase inhibitor that interferes with
the autophagosome–lysosome fusion) (50) and ammonium chloride (disrupts
trafficking and lysosomal processing of proteins) (51) or MG132 (a protea-
somal inhibitor) (18). Twelve hours after the treatment, GFP-positive cells
showing the apoptotic features were scored in a blinded manner. The value
of each bar represents the mean average of three independent transfections,
with a minimum of 250 GFP-positive cells scored for each transfection.
Error bars indicate the SD of the mean. The difference in the P-value
,0.05 or 0.005 was denoted over the bar by a single or double asterisk (),
respectively, as derived from a paired t-test.
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were a gift from Peter Lansbury (Harvard Medical School,
Boston, MA, USA). The pcDNA3 expression plasmids encod-
ing wild-type HA-tagged Hsp70 were gift of Harm
H. Kampinga (University Medical Center Groningen, The Neth-
erlands). The antisense Hsp70 pcDNA3 plasmid, containing a
500 bp fragment of the human hsp70 cDNA in the antisense
orientation (974–475 bp), was a kind gift of M. Jaattela (Institute
for Cancer Biology, Denmark) (49). The mutant ubiquitin con-
struct (K48R) was provided by Lih-Shen Chin (Emory University
School of Medicine, USA), and the wild-type ubiquitin construct
was generated by amplifying the coding sequence from cDNA
and cloning into a pcDNA 3.1 vector. The pCMV-LacZ construct
was generously provided by Jonaki Sen (Indian Institute of Tech-
nology, Kanpur, India). The RNAi constructs for laforin and
malin (shRNAmir) were purchased from Open Biosystem,
USA (Expression ArrestTM microRNA-adapted shRNA libraries)
and were validated for their efficiency of knockdown (see Sup-
plementary Material, Fig. S4).
Cell culture and transfection
COS-7 and Neuro2A cells were grown in Dulbecco’s modified
Eagle’s medium (Sigma-Aldrich India Pvt Ltd) supplemented
with 10% (v/v) fetal calf serum, 100 U/ml penicillin and
100 mg/ml streptomycin. All cells were grown at 378C in
5% CO2. Transfection was performed using LipofectAMINE
2000 transfection reagent (Invitrogen Inc., USA), according
to the manufacturer’s protocol. Cells were harvested at 24 h
or later as indicated.
Blockers for autophagy–lysosome and proteasome
pathways
Transiently transfected cells were allowed to express the
desired proteins for 12 h and then incubated for further 12 h
in the medium containing one of the following inhibitors;
20 mM MG132 (Calbiochem, USA), 25 mM ammonium
chloride (Merck, India), 10 mM 3-methyladenine (3-MA,
Sigma-Aldrich India Pvt Ltd) or 200 nM bafilomycin A1
(Sigma-Aldrich India Pvt Ltd). Control experiments using
the resuspension solvents dimethyl sulfoxide or distilled
water were performed where appropriate. See legend to
Figure 8 for details on blockers.
Pulse-chase analysis
The COS-7 cells were transiently transfected with an inducible
version of expression construct that codes for His-tagged
Figure 9. The malin–laforin complex suppresses the cellular toxicity of misfolded proteins with the help of Hsp70. (A) Levels of toxicity of tHtt-Q97-GFP in
COS-7 cells co-expressing malin and Hsp70 or its antisense construct (AsHsp70) (49). (B) Levels of toxicity of tHtt-Q97-GFP in COS-7 cells co-expressing
laforin and Hsp70 or its antisense construct (AsHsp70). (C) Overexpression of Hsp70 does not suppress the toxicity of misfolded proteins in the absence of
malin or laforin. COS-7 cells were co-transfected with the construct for tHttQ97-GFP, overexpression or a knockdown construct for Hsp70 and knockdown
construct for laforin or malin as indicated, and the toxicity was scored. The value of each bar represents the mean of three independent transfections, with a
minimum of 300 cells scored for each set. Error bars represent the SD of the mean. The P-value ,0.005, calculated by a paired t-test, is denoted over the
bar by double asterisks (). The efficiency of knockdown by the AsHsp70 construct was established earlier (48) and in the present study by immunoblotting
(see Supplementary Material, Fig. S4B). (D) COS-7 cells were transfected with the expression construct coding Myc/His-tagged malin, laforin or an empty
vector (pcDNA) and processed for pull-down assay using the Ni-affinity resin. The pulled-down products (PD) and the whole cell lysates (WCLs) were immu-
noblotted (IB) with anti-Hsp70 and anti-Myc antibodies, as indicated. (E) COS-7 cells were transiently co-transfected with a combination of various constructs as
indicated in the figure and processed for pull-down assay using the Ni-affinity resin. The PD and the WCLs were IB with anti-Hsp70 and anti-Myc antibodies, as
indicated. (F) COS-7 cells were transiently transfected with expression construct for GFP-D20, antisense Hsp70 (AsHsp70) and laforin or malin and processed
for pull-down assay using the Ni-affinity resin. The PD and the WCLs were IB with anti-GFP and anti-Myc antibodies, as indicated.
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tHtt-Q97-GFP (28) and wild-type or the mutant forms of
malin (C26S) or laforin (Q293L) (18). Twenty four hours
post-transfection, the cells were treated with ponasterone
A (5 mM/ml) for 12 h. The cells were then washed with
phosphate-buffered saline (PBS) and harvested at 0, 2.5, 5 or
10 h with the addition of a fresh medium.
Immunocytochemistry and counting of aggregates
and apoptotic cells
COS-7 cells, grown on gelatin-coated sterile glass cover slips,
were fixed and processed for immunofluorescence microscopy
essentially as described earlier (18). Cells were fixed with par-
aformaldehyde (4%), permeabilized (0.05% Tween 20) and
subsequently incubated with primary and secondary anti-
bodies. For nuclear staining, fixed cells were incubated with
10 mM 40,6-diamidino-2-phenylindole (DAPI). GFP-positive
cells showing apoptotic bodies (see Supplementary Material,
Fig. S1H0 and K0) or aggregate formation (for tHtt-Q97-GFP)
(Fig. 10A) were manually counted under the fluorescence
microscope (250 transfected cells in each set), and the cells
containing more than one aggregate were considered to
have a single aggregate. Experiments were repeated at
least thrice, and counts were made in a blinded manner. For
double immunofluorescence staining of the R6/2 transgenic
mice brain sections, the anti-huntingtin (S830) and anti-laforin
or anti-malin antibodies were reacted and processed for
imaging as described previously (44). Fluorescence images
were obtained using a fluorescence microscope (Nikon
Eclipse 80i, Japan) with a 40 objective lens and were pro-
cessed using ImageExpress software (Media Cybernetics,
Figure 10. Malin and laforin associate with cellular aggregates of
tHtt-Q97-GFP and facilitate their clearance. Expression constructs encoding
tHtt-Q97-GFP and malin or laforin were transiently co-expressed in COS-7
cells and subjected to immunostaining. (A) Co-localization of malin or
laforin with the tHtt-Q97-GFP (GFP-Q97) aggregates as indicated (identified
by arrow). Scale bar, 10 mm. (B) Malin and laforin reduce the frequency of
transfected cells forming cytoplasmic aggregates of tHtt-Q97-GFP. COS-7
cells were transiently transfected with tHtt-Q97-GFP with an empty vector
(shRNA vector), an expression vector for wild-type malin (malin-WT), wild-
type laforin (laforin-WT), knockdown construct for laforin or the knockdown
construct for malin, and aggregate-positive cells were scored 24 h after trans-
fection. The value of each bar represents the mean average of three indepen-
dent transfections, with a minimum of 250 transfected cells scored for each
transfection. Error bars indicate the SD of the mean. The difference in the
P-value ,0.05 was denoted over the bar by an asterisk (), as derived from
a paired t-test. (C) Immunoblot analysis of the tHtt-Q97-GFP protein retained
in the stacking gel. Expression constructs encoding tHtt-Q97-GFP, malin or
laforin were expressed either separately or in a combination as indicated,
and the cell lysates were immunoblotted with anti-GFP and anti-g-tubulin
antibodies as indicated. The arrow mark and the arrow head identify, respect-
ively, the high-molecular-weight species trapped in the stacking gel and the
expected size peptide for the tHtt-Q97-GFP protein. Horizontal line identifies
the beginning of the stacking gel.
Figure 11. Co-localization of malin and laforin with the huntingtin aggregates
in the neurons of transgenic mice model (R6/2) for Huntington disease (31).
Sections from the adult mice brains (R6/2 transgenic line) were immunor-
eacted with anti-huntingtin (raised in goat—1:500 dilution) and anti-malin
(raised in mouse—1:100 dilution) (top panel) or anti-laforin (raised in
mouse—1:100 dilution) (lower panel). Arrows indicate the aggregates of
expanded huntingtin that co-localize with malin or laforin. The merged
images also show the DAPI staining for the nucleus (scale bar, 20 mm). The
specificity of anti-laforin and anti-malin antibodies was established in cell
lines (see Supplementary Material, Fig. S4C and D), and using the tissue
lysates of laforin-deficient mice for the anti-laforin antibody (52).
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USA). Representative images were then imported to Photo-
shop (Adobe) for processing.
Pull-down experiments
To establish the physical interaction between malin or laforin
and other target proteins, we used the expression constructs
that code for Myc/His-tagged malin and laforin (18) or the
His-tagged tHtt-Q97-GFP (28). Lysates of cells that had
expressed His-tagged malin or laforin with the desired protein
were incubated with Ni-affinity resin (Sigma-Aldrich India
Pvt Ltd) for 1 h at 48C and processed for pull-down assays as
recommended by the manufacturer. Pulled-down products
were detected by immunoblotting using specific antibodies.
Ubiquitination assay
Cells that were expressing the His-tagged tHtt-Q97-GFP
(either alone or along with laforin or malin) were processed
for the Ni-affinity pull down assay, as described above. The
pulled-down products were transferred to a membrane and
reacted with specific antibodies.
Immunoblotting analysis
Protein samples were run on a 10% sodium dodecyl sulfate
(SDS)–polyacrylamide gel electrophoresis (PAGE) and trans-
ferred onto a nitrocellulose filter (MDI, India), as described
previously (18). After blocking with 5% non-fat dry milk
powder in 1 PBS, the membranes were processed through
sequential incubations with primary antibody, followed by
secondary antibody at dilutions as recommended by the
manufacturer. Immunoreactive proteins on the filter were
visualized using a chemiluminscent detection kit (SuperSignal
West PICO, Pierce, USA).
Statistical analysis
Standard deviations (SDs) for the observed values were
calculated and plotted for every experiment, and statistical
significance was tested with two-tailed paired t-test (P , 0.05)
using the GraphPad software.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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